Wednesday, October 17, 2007 12:00:00 AM
By that time, they would probably be worth about 40 cents a share. Who would want to do that?
Will you be hiring any professional pharma executives?
Why bother? Does it really look like they will ever put a product out?
18 months ago, Seymour said "INDA's in 18 months."
Now, if you read the annual report, they say, "INDA's in the 2008-2009 fiscal year". If it happens halfway through the year that means... INDA's in 18 months.
18 months from now... look forward to hearing the same thing.
Face it, they don't have a clue as to when anything will be done. Or where the money to fund all these projects would come from. They constantly issue guesses and goals and projections that never pan out.
If the Dengue studies perform well, whats the next step?
What Dengue studies? The filing lists the current dengue drug status as "early R & D", same as the HIV drugs. Not even in preclinical testing.
Will there be a program to create investor awareness about NNVC?
People are already aware of NNVC. They just don't like it.
Is it possible to collaborate with Big Pharma before Human studies?
What exactly about this operation would impress Big Pharma? The lack of funding, or the lack of results?
Hype is a dangerous tool in the wrong hands.
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM